AriBioLab Co.,Ltd. (KOSDAQ:261780)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,300.00
+450.00 (11.69%)
At close: Nov 6, 2026

AriBioLab Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
120,46075,89482,084151,036131,749293,364
Market Cap Growth
65.76%-7.54%-45.65%14.64%-55.09%-
Enterprise Value
111,00855,70553,558123,50097,133290,192
Last Close Price
4300.002825.003060.005650.004985.0011100.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
695.66478.48221.45513.51734.04586.73
PB Ratio
12.186.402.964.263.957.41
P/TBV Ratio
12.486.532.984.273.957.41

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-351.19144.49419.89541.18580.38

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.630.750.350.120.710.53
Net Debt / Equity Ratio
-0.96-1.25-1.10-0.98-1.02-1.03
Net Debt / EBITDA Ratio
0.751.074.245.875.646.97
Net Debt / FCF Ratio
1.031.333.696.206.067.51
Asset Turnover
0.010.000.010.010.000.01
Quick Ratio
1.651.494.2148.572.182.50
Current Ratio
1.921.664.6452.442.202.50
Return on Equity (ROE)
-92.28%-81.07%-32.11%-5.09%-18.40%-89.44%
Return on Assets (ROA)
-25.28%-23.16%-10.42%-7.56%-6.40%-8.35%
Return on Capital Employed (ROCE)
-113.10%-105.00%-20.50%-14.50%-18.90%-15.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.48%-21.14%-12.35%-1.16%-5.10%-6.28%
FCF Yield
-7.64%-14.67%-10.08%-3.69%-4.28%-1.85%
Buyback Yield / Dilution
-0.19%-0.13%-1.18%-0.30%-13.35%-30.03%